Carrier-mediated transport as a common route of antibiotic ingress into bacteria
mBio · 2025
DOI: 10.1128/mbio.01616-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Justin E Clarke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteria, Membrane Transport Proteins, Carrier Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Ministry of Higher Education, Saudi Arabia.
Abstract (Originalsprache)
Among the most significant challenges in antibacterial discovery is achieving delivery of small molecule inhibitors across the bacterial membrane(s) to reach their intracellular targets. It is considered axiomatic that the typical route for antibiotics across the cytoplasmic membrane (CM) involves diffusion directly through the lipid bilayer, though this concept has not translated into actionable information for rationally achieving ingress of inhibitors into bacteria. Here, using antibiotic accumulation measurements in bacteria inactivated for individual or multiple CM transporters, we provide evidence that a diverse range of established antibiotic classes are transported across the CM by hitch-hiking on carrier proteins. The chemical similarity between some antibiotic classes and the native substrate(s) of the importer they share provides a molecular logic for drug transport. Our results indicate that carrier-mediated uptake is a common route of antibiotic entry into bacteria and highlight the value of metabolite mimicry in designing new antibacterial drugs. IMPORTANCE Increasing antibiotic resistance among pathogenic bacteria is undermining our ability to treat infection, and new antibacterial drugs are urgently needed to address the problem. One of the most significant challenges in antibacterial discovery is achieving delivery of inhibitors across the bacterial membrane(s) to reach their intracellular targets, reflecting the lack of a granular understanding about how antibiotics enter bacteria. Here, we provide evidence that a common route for established antibiotics into bacteria involves uptake by membrane transport proteins. Our findings thereby offer a clear route forward for antibacterial discovery: mimicry of the natural substrates of transporter proteins to achieve carrier-mediated uptake of inhibitors into the bacterial cell.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
- School of Molecular & Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
- School of Chemistry, University of Leeds, Leeds, United Kingdom.
ORCID-Profile: Alex J O'Neill
Förderung
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Ministry of Higher Education, Saudi Arabia
Zitieren
APA
Clarke, J. E., Galarion, L. H., Almadani, A. A., Smith, C. N. A., Wright, J. D., Warriner, S. L., & O'Neill, A. J. (2025). Carrier-mediated transport as a common route of antibiotic ingress into bacteria. mBio. https://doi.org/10.1128/mbio.01616-25
Vancouver
Clarke JE, Galarion LH, Almadani AA, Smith CNA, Wright JD, Warriner SL, et al. Carrier-mediated transport as a common route of antibiotic ingress into bacteria. mBio. 2025. doi:10.1128/mbio.01616-25
BibTeX
@article{Clarke2025,
author = {Clarke, Justin E and Galarion, Luiza H and Almadani, Abdulmenem A and Smith, Christopher N A and Wright, John D and Warriner, Stuart L and O'Neill, Alex J},
title = {Carrier-mediated transport as a common route of antibiotic ingress into bacteria},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.01616-25}
}
EUVIMED